Stratasan
Acquired5 known investors
Nashville-based healthcare analytics provider giving hospitals market intelligence for strategic growth planning; acquired by Syntellis in 2022.
Also known as Stratasan, LLC
Investors Β· 5
Also in the syndicate Β· 1
Company profile
researched Aug 2026Stratasan is a healthcare data analytics company based in Nashville, Tennessee, that provides web-based software and professional services delivering market intelligence to hospitals and health systems. Its tools are used by strategic planners, marketers, physician relations teams and business development staff to define target markets, identify growth opportunities, locate patient populations and track progress against strategic goals. The company builds cloud-based applications on top of curated healthcare data layers, supporting all-payer claims data (APCD) alongside state, Medicare, EMR and internal patient datasets.
The product portfolio described by the company includes an analytics platform organized into three components β Blackbird for experienced analysts querying complex datasets, Canvas for field users working from templated reports, and Gallery for delivering refreshed reports to C-suite administrators β as well as a Pathway software suite comprising Physician Pathway, which reports on inbound and outbound physician referral relationships, and Launch Pathway, a visual intelligence platform for translating market data into service-line and demographic insights. Alongside the software, Stratasan's Spark Services team of healthcare professionals and in-house analysts performs data collection, extraction, transformation and quality assurance, mapping clinical codes (MS-DRG, ICD-9, CPT, HCPCS) to descriptions and validating volumes, discharges and product-line comparisons before data is loaded into the platform. Customers served include hospitals, surgery centers, pharmaceutical companies, health plans, physician offices and communities.
Founding story
Stratasan was founded in 2010 by Jason Moore and Brian Dailey, who drew on prior advisory relationships with hospitals and identified a need for a product-focused, customer-centric company to help health systems access and leverage healthcare data for strategic growth planning. Moore served as co-founder and CEO and framed the company's approach around the data-information-knowledge-wisdom (DIKW) hierarchy as a model for how healthcare leaders extract value from data.
Business model
Stratasan sells subscription access to proprietary web-based analytics software layered over licensed and curated healthcare datasets, combined with professional and data-processing services (Spark Services, custom builds, consulting on data availability) delivered by in-house healthcare analysts.
Recurring revenue from software subscriptions to its analytics platform and Pathway suite, supplemented by fees for data processing, custom builds and Spark Services professional/analytic engagements.
Traction
At the time of the July 2019 financing, Stratasan reported partnering with more than 1,000 hospitals from leading U.S. health systems across more than 40 states; an earlier company profile cited more than 900 hospitals across 41 states. Headcount grew from fewer than 20 employees to more than 100 by the 2022 sale. Revenue growth earned a No. 4,350 placement on the 2021 Inc. 5000, and a case-study account of its operating-framework adoption cites a 20%+ productivity gain, 30% turnover reduction and 80% employee engagement.
Latest developments
Syntellis Performance Solutions announced a definitive agreement to acquire Stratasan on July 11, 2022, after which Stratasan operated as a Syntellis-owned healthcare data analytics firm; Blue Heron Capital records the investment as exited. In August 2022 the company supplied data for a ClearHealthCosts analysis of joint replacement volumes shifting to hospital outpatient departments and ambulatory surgery centers. Co-founder and CEO Jason Moore and COO Haley Devlin have since become partners at DNA Partners, coaching other leadership teams.
βΈFull profile β market position, technology, go-to-market, geography, history, risks & controversies
Market position
Positioned as a specialist provider of healthcare market intelligence and strategic planning analytics for hospitals and health systems, serving more than 1,000 hospitals across 40-plus states at the time of its 2019 financing. It was named a Top 10 Healthcare Startup for 2017 by Healthcare Tech Outlook and placed No. 4,350 on the 2021 Inc. 5000. Comparable and adjacent vendors in healthcare data and analytics include Healthcare Bluebook, Change Healthcare, IQVIA, Inovalon and LexisNexis Risk Solutions.
The company combines ownership of the technology powering its datasets with in-house data curation and analyst services, which it says enables faster response times, custom builds and stronger product support than data-only vendors. Its data processing service takes each dataset through quality assurance to flag discrepancies and confirm currency, relieving hospitals of the work of purchasing and cleaning state and Medicare data themselves, while Spark Services provides healthcare-experienced staff to supplement customers' internal analytic capacity.
Technology
Cloud-based analytics applications built on curated healthcare data layers covering all-payer claims, state, Medicare, EMR and internal patient data. The platform is segmented into Blackbird (complex dataset querying for analysts), Canvas (templated reports for field users) and Gallery (refreshed report delivery for executives), with the Pathway suite adding Physician Pathway for referral analysis and Launch Pathway for visual market and service-line intelligence. Data passes through a rigorous quality-assurance pipeline that flags discrepancies, checks currency, maps MS-DRG/ICD-9/CPT/HCPCS codes to descriptions and validates volumes and product-line comparisons. Reported technologies in use include Looker, Google Cloud, React, Amazon Route 53, Adobe, ADP and Microsoft Active Directory.
Go-to-market
Direct enterprise sales to hospitals and health systems, supported after the 2019 financing by planned investment in sales, marketing and customer success teams. Consultative onboarding β where the data team first verifies that required datasets exist and validates quarterly and annual trends β and ongoing analyst support form part of the customer relationship, complemented by industry recognition, published research collaborations and content marketing.
Hospitals and multi-hospital health systems β particularly their strategic planning, marketing, physician relations, business development and executive teams β as well as surgery centers, pharmaceutical companies, health plans, physician offices and community organizations.
Geography
Headquartered in Nashville, Tennessee, with a remote-first workforce hiring across the United States and customers spanning more than 40 states.
History
The company was founded in 2010 to change how hospitals and health systems access and use healthcare data. Shortly after raising initial funding, one of the largest U.S. health systems signed on as its first partner and spent roughly six months co-designing the core software application with the Stratasan team, a product that later became widely used across the customer base. The company adopted the EOS operating framework and, beginning in Q1 2020, worked with facilitator Benj Miller as what it was told was the first client of the System & Soul framework, during a period when it shifted from office-based to fully remote work and grew from under 20 employees to more than 100. It raised $26 million in July 2019 in a round led by Fulcrum Equity Partners, was ranked No. 4,350 on the 2021 Inc. 5000, and was acquired by Syntellis Performance Solutions in July 2022 in what its founders described as a nine-figure exit.
Risks & controversies
Public accounts describe scaling difficulties before the acquisition, including unclear roles, inconsistent accountability, weak leadership infrastructure, dipping morale and elevated turnover in departments such as business development, with investors pressing the leadership team to move from startup practices to a scalable platform. As a business dependent on state hospital association, Medicare, EMR and all-payer claims datasets, the company relies on third-party data availability and quality.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Timeline Β· 7
launches, deals, and filingsClearHealthCosts worked with Stratasan to track the shift of joint replacements to hospital outpatient departments and ambulatory surgery centers over a five-year period.
Stratasan, LLC was recognized by the National Association for Business Resources as one of Nashville's Best & Brightest Companies to Work For.
Syntellis Performance Solutions, LLC, a provider of enterprise performance management software, data and intelligence solutions, announced a definitive agreement to acquire Stratasan, described as an industry leader in advanced healthcare market intelligence and data analytics. Stratasan subsequently operated as a Syntellis-owned healthcare data analytics firm. Company principals later characterized the 2022 sale as a nine-figure exit.
Stratasan began offering ZIP5-level analysis of its All-Payer Claims Database.
Inc. magazine ranked Stratasan No. 4,350 on its annual Inc. 5000 list of the fastest-growing private companies in the United States.
Stratasan partnered with third-party firm Courage Collective to launch an organization-wide diversity, equity and inclusion initiative.
Healthcare Tech Outlook Magazine recognized Stratasan in its Top 10 Healthcare Startups 2017 listing.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
βΈResearch sources Β· 8
primary sources listed
- Stratasan Company Overview, Contact Details & Competitors | LeadIQleadiq.com Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Stratasan do?
- Nashville-based healthcare analytics provider giving hospitals market intelligence for strategic growth planning; acquired by Syntellis in 2022.
- Who are Stratasan's investors?
- Stratasan's investors include Frist Cressey Ventures, Fulcrum Equity Partners, Blue Heron Capital, Bridge Bank.
